PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
INFI vs. INFN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between INFI and INFN is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

INFI vs. INFN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Infinity Pharmaceuticals, Inc. (INFI) and Infinera Corporation (INFN). The values are adjusted to include any dividend payments, if applicable.

0.00%5.00%10.00%SeptemberOctoberNovemberDecember2025February0
7.97%
INFI
INFN

Key characteristics

Fundamentals

Market Cap

INFI:

$726.09K

INFN:

$1.57B

EPS

INFI:

-$0.44

INFN:

-$0.47

PEG Ratio

INFI:

-0.05

INFN:

-0.76

Returns By Period


INFI

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

INFN

YTD

1.22%

1M

0.91%

6M

7.95%

1Y

30.14%

5Y*

-3.87%

10Y*

-9.33%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

INFI vs. INFN — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INFI

INFN
The Risk-Adjusted Performance Rank of INFN is 6969
Overall Rank
The Sharpe Ratio Rank of INFN is 7171
Sharpe Ratio Rank
The Sortino Ratio Rank of INFN is 6868
Sortino Ratio Rank
The Omega Ratio Rank of INFN is 7272
Omega Ratio Rank
The Calmar Ratio Rank of INFN is 6363
Calmar Ratio Rank
The Martin Ratio Rank of INFN is 7373
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

INFI vs. INFN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Infinity Pharmaceuticals, Inc. (INFI) and Infinera Corporation (INFN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
No data
The chart of Calmar ratio for INFI, currently valued at 0.00, compared to the broader market0.002.004.006.000.000.44
INFI
INFN


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
1.00
0.80
INFI
INFN

Dividends

INFI vs. INFN - Dividend Comparison

Neither INFI nor INFN has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

INFI vs. INFN - Drawdown Comparison


-100.00%-95.00%-90.00%-85.00%-80.00%-75.00%SeptemberOctoberNovemberDecember2025February
-99.99%
-75.42%
INFI
INFN

Volatility

INFI vs. INFN - Volatility Comparison

The current volatility for Infinity Pharmaceuticals, Inc. (INFI) is 0.00%, while Infinera Corporation (INFN) has a volatility of 1.68%. This indicates that INFI experiences smaller price fluctuations and is considered to be less risky than INFN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%2.00%4.00%6.00%8.00%SeptemberOctoberNovemberDecember2025February0
1.68%
INFI
INFN

Financials

INFI vs. INFN - Financials Comparison

This section allows you to compare key financial metrics between Infinity Pharmaceuticals, Inc. and Infinera Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab